Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: oral terbinafine 250mg: oral terbinafine 250 mg once daily dosag in suoerficial dermatophytic infections .Total duration of treatment 12 weeks. Route of administration oral.
Interventi
Sponsors
Rohilkhand Medical college and Hospitalr
Eligibility
Inclusion criteria
Inclusion criteria: any person older than 18 years with dermatophytic infections diagnosed by physical examination or 10%KOH mount if required .
Exclusion criteria
Exclusion criteria: 1.patient receiving antimycotic treatment in last 3 months 2. pregnant or lactating women 3. patients of any chronic of life threatning diseases . 4 taking systemic steroids or any other immunosuppressive drug for any other reason .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to study comparitive efficacy of itraconazole vs terbinafine in treatment of dermatophytic infections after 12 weeks of treatmentTimepoint: patients will be evaluated at 12weeks after intiation of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| compare efficacy of itraconazole vs terbinafine in treatment of superficial dermatophytic infectionsTimepoint: patients will be evaluated for secondary outcome at 4th and 8th week | — |
Countries
India
Contacts
Public ContactDR PRAVEEN KUMAR RATHORE
ROHILKHAND MEDICAL COLLEGE AND HOSPITAL PILIBHIT BYPASS ROAD BAREILLY UP
Outcome results
None listed